Biostem Technologies

Biostem Technologies Capital Intensity

The Capital Intensity Ratio of Biostem Technologies (BSEM) as of Nov 19, 2026 is 46.51 %. In the previous year, Capital Intensity Ratio was 87.26 % — a change of -46.70% (lower).

Capital Intensity

46.51 %

YoY

-46.70%

Last updated:

Capital Intensity Ratio of Biostem Technologies is 2024 46.51 % . Capital Intensity Ratio of Biostem Technologies was 2023 87.26 % . It decreases by -46.70% lower compared to the previous year.

The Biostem Technologies Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2017
923.25 USD
Jan 1, 2018
422.75 USD
Jan 1, 2019
119.91 USD
Jan 1, 2020
105.81 USD
Jan 1, 2021
61.54 USD
Jan 1, 2022
50.42 USD
Jan 1, 2023
87.26 USD
Jan 1, 2024
46.51 USD
The Biostem Technologies Capital Intensity history
YEARCapital IntensityYoY
46.51 %-46.70%
87.26 %+73.08%
50.42 %-18.08%
61.54 %-41.84%
105.81 %-11.76%
119.91 %-71.63%
422.75 %-54.21%
923.25 %+104.75%
450.91 %-76.73%
1,937.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biostem Technologies Stock analysis

What does Biostem Technologies do? Biostem Technologies Inc is a US company specializing in regenerative medicine. It was founded in 2007 and is based in Clearwater, Florida. Biostem Technologies is listed on the OTCQB Stock Exchange and offers a wide range of products in the field of regenerative medicine. The company's business model primarily involves advancing growth in the field of regenerative medicine through the development and marketing of new products and technologies. They focus on the production of stem cells that can be used in the regeneration of damaged tissues and organs. They also offer research and development of stem cell therapies, manufacturing of stem cell products, and related services. Biostem Technologies places emphasis on processing umbilical cord blood stem cells, collaborating with medical facilities to collect and isolate these cells for preservation. The company has also developed products such as BioStem Serum and BioStem Gel, made from stem cells and used in regeneration and wound healing. They have developed technologies for regenerating damaged tissues and organs, including a technology for regenerating muscle and adipose tissue through stem cell injection. Clinical studies have shown promising results with this technology. Biostem Technologies has partnerships with other companies and institutes in the field of regenerative medicine, including working with the National Institute of Neurological Disorders and Stroke to develop a new therapy for multiple sclerosis. They also provide consulting services to assist other companies in developing regenerative products and services. In conclusion, Biostem Technologies is a leading company in the field of regenerative medicine and stem cell therapies, offering a range of products and services. They also provide important technologies for tissue regeneration, positioning them as a key player in the field of regenerative medicine. Biostem Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biostem Technologies stock

Capital Intensity Ratio of Biostem Technologies is 46.51 % in 2024.

Capital Intensity Ratio of Biostem Technologies changed from 87.26 % to 46.51 %, representing a -46.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Biostem Technologies since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Biostem Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Biostem Technologies

All Key Metrics — Biostem Technologies